XTLB

XTL Biopharmaceuticals
XTLB

4 hedge funds and large institutions have $596K invested in XTL Biopharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$949

Top Sellers

1
-$35K
2
-$26K
3
-$3.44K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$272K
2
$272K
3
$50K
4
$2K
5
–
6
–